Paper6136359
A new oral renal vasodilator, fenoldopam.
Stote RM and 4 others. Clin Pharmacol Ther, 1983. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. A new oral renal vasodilator, fenoldopam. Papers, record 6136359. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6136359
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzazepines | Major topic |
| Kidney | Major topic |
| Receptors, Dopamine | Major topic |
| Urination | Major topic |
| Vasodilator Agents | Major topic |
| Adult | |
| Diuresis | |
| Drug Evaluation | |
| Drug Interactions | |
| Fenoldopam | |
| Humans | |
| Male | |
| Metoclopramide |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35230705 | Fenoldopam Sensitizes Primary Cilia-Mediated Mechanosensing to Promote Osteogenic Intercellular Signaling and Whole Bone Adaptation. | J Bone Miner Res | 2022 | https://conductscience.org/library/papers/35230705 | PubMed |
| 31553283 | Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics. | Curr Top Med Chem | 2019 | https://conductscience.org/library/papers/31553283 | PubMed |
| 23733636 | Dopamine and renal function and blood pressure regulation. | Compr Physiol | 2011 | https://conductscience.org/library/papers/23733636 | PubMed |
| 6378230 | Lack of effect of ibopamine, a dopamine pro-drug, on renal function in normal subjects. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6378230 | PubMed |
| 6150942 | Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6150942 | PubMed |
| 2897206 | Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/2897206 | PubMed |
| 2896014 | Continuous intragastric delivery of fenoldopam: relationship between plasma concentration and effects on renal function. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/2896014 | PubMed |
| 2894216 | Effects of fenoldopam, a specific dopamine receptor agonist, on blood pressure and left ventricular function in systemic hypertension. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/2894216 | PubMed |
| 2878679 | The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/2878679 | PubMed |
| 2868748 | Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/2868748 | PubMed |
| 2858215 | The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/2858215 | PubMed |
| 2574187 | Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2574187 | PubMed |
| 2573341 | Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure. | Basic Res Cardiol | 1989 | https://conductscience.org/library/papers/2573341 | PubMed |
| 2573048 | A retrospective analysis of fenoldopam renal excretion in 65 subjects: evidence for possible intrarenal formation of fenoldopam from its metabolites. | Pharm Res | 1989 | https://conductscience.org/library/papers/2573048 | PubMed |
| 2571297 | Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat. | Am J Pathol | 1989 | https://conductscience.org/library/papers/2571297 | PubMed |
| 2474354 | The action of dopamine and vascular dopamine (DA1) receptor agonists on human isolated subcutaneous and omental small arteries. | Br J Pharmacol | 1989 | https://conductscience.org/library/papers/2474354 | PubMed |
| 2060557 | Metoclopramide, domperidone and dopamine in man: actions and interactions. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/2060557 | PubMed |
| 1967532 | Haemodynamic and pharmacokinetic study of intravenous fenoldopam in patients with hepatic cirrhosis. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/1967532 | PubMed |
| 1676367 | A single dose study of the effects of fenoldopam and enalapril in mild hypertension. | Eur J Clin Pharmacol | 1991 | https://conductscience.org/library/papers/1676367 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6136359
GET https://conductscience.org/api/papers/v1/6136359/authors